Cargando…
Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in Mesenteric Venous Thrombosis
BACKGROUND: Monotherapy with anticoagulation has been considered as first-line therapy in patients with mesenteric venous thrombosis (MVT). The aim of this study was to evaluate outcome, prognostic factors, and failure rate of anticoagulation as monotherapy, and to identify when bowel resection was...
Autores principales: | Salim, S., Zarrouk, M., Elf, J., Gottsäter, A., Ekberg, O., Acosta, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182753/ https://www.ncbi.nlm.nih.gov/pubmed/29777267 http://dx.doi.org/10.1007/s00268-018-4667-x |
Ejemplares similares
-
Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study
por: Salim, Saman, et al.
Publicado: (2019) -
Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis
por: Montiel, Francisco Sánchez, et al.
Publicado: (2017) -
Management of Acute Mesenteric Venous Thrombosis: A Systematic Review of Contemporary Studies
por: Acosta, S., et al.
Publicado: (2020) -
Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism
por: Ghazvinian, R., et al.
Publicado: (2018) -
Is it safe to withhold long-term anticoagulation therapy in patients with small pulmonary emboli diagnosed by SPECT scintigraphy?
por: Ghazvinian, R., et al.
Publicado: (2016)